HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced heterochromatin protein 1-beta (HP1beta) expression is correlated with increased invasive activity in human melanoma cells.

Abstract
Heterochromatin protein 1 (HP1) is associated with heterochromatin formation and the regulation of gene expression. In this study, we demonstrated that decreased HP1beta, but not HPla, mRNA and protein expression, correlates with invasive potential in five human melanoma cell lines, and we used immunohistochemistry to confirm that HP1beta expression is suppressed during melanoma progression. HPIP levels are decreased in (V600E)B-RAF-transformed mouse melanocytes, suggesting that HP1beta-mediated suppressive mechanisms correlate with melanoma oncogenesis. Expression of microphthalmia associated-transcription factor (MITF), an important melanocyte differentiation factor, is reduced in melanoma, which is correlated with poor prognosis. In CRL1579, SK-MEL-28 and HMV-II human melanoma cells in which HP1beta expression is reduced by RNAi, MITF RNA levels and invasiveness activities are differentially altered and are not correlated with each other. Our findings indicate that the (V600E)B-RAF mutation induces HPIbeta down-regulation, which causes epigenetic gene regulation associated with melanoma progression.
AuthorsKeisuke Nishimura, Yoshifumi S Hirokawa, Hitoshi Mizutani, Taizo Shiraishi
JournalAnticancer research (Anticancer Res) 2006 Nov-Dec Vol. 26 Issue 6B Pg. 4349-56 ISSN: 0250-7005 [Print] Greece
PMID17201154 (Publication Type: Journal Article)
Chemical References
  • CBX1 protein, human
  • Chromosomal Proteins, Non-Histone
  • DNA Primers
  • RNA, Messenger
  • Chromobox Protein Homolog 5
Topics
  • Base Sequence
  • Cell Line, Tumor
  • Chromobox Protein Homolog 5
  • Chromosomal Proteins, Non-Histone (genetics)
  • DNA Primers
  • Down-Regulation
  • Humans
  • Immunohistochemistry
  • RNA Interference
  • RNA, Messenger (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: